Advertisement

Where to Target? The Precision Medicine Approach to Brain Stimulation

  • David P. McMullen
    Correspondence
    Address correspondence to David P. McMullen, M.D., National Institute of Mental Health, Division of Translational Research, 6001 Executive Blvd., Rm. 7129, Neuroscience Center, MSC 9632, Bethesda, MD 20892.
    Affiliations
    Division of Translational Research, National Institute of Mental Health, Bethesda, Maryland
    Search for articles by this author
      SEE CORRESPONDING ARTICLE ON PAGE 28
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weigand A.
        • Horn A.
        • Caballero R.
        • Cooke D.
        • Stern A.P.
        • Taylor S.F.
        • et al.
        Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites.
        Biol Psychiatry. 2018; 84: 28-37
        • Dunlop B.W.
        • Rajendra J.K.
        • Craighead W.E.
        • Kelley M.E.
        • McGrath C.L.
        • Choi K.S.
        • et al.
        Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder.
        Am J Psychiatry. 2017; 174: 533-545
        • Drysdale A.T.
        • Grosenick L.
        • Downar J.
        • Dunlop K.
        • Mansouri F.
        • Meng Y.
        • et al.
        Resting-state connectivity biomarkers define neurophysiological subtypes of depression.
        Nat Med. 2017; 23: 28-38
        • Insel T.R.
        • Cuthbert B.N.
        Brain disorders? Precisely.
        Science. 2015; 348: 499-500
        • George M.S.
        • Lisanby S.H.
        • Avery D.
        • McDonald W.M.
        • Durkalski V.
        • Pavlicova M.
        • et al.
        Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial.
        Arch Gen Psychiatry. 2010; 67: 507-516
        • Fox M.D.
        • Buckner R.L.
        • White M.P.
        • Greicius M.D.
        • Pascual-Leone A.
        Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.
        Biol Psychiatry. 2012; 72: 595-603
        • National Institutes of Health website
        NIMH only accepts clinical trial applications proposing mechanistic studies for clinical trial parent R01 and R21 announcements.
        (Available at:) (Accessed April 2, 2018)
        • National Institute of Mental Health website
        Support for clinical trials at NIMH.
        (Available at:) (Accessed April 2, 2018)
        • National Institute of Mental Health website
        NIMH non-invasive brain stimulation e-field modeling workshop.
        (Available at:) (Accessed April 2, 2018)
        • Anderson L.
        • Antkowiak P.
        • Asefa A.
        • Ballard A.
        • Bansal T.
        • Bello A.
        • et al.
        FDA regulation of neurological and physical medicine devices: Access to safe and effective neurotechnologies for all Americans.
        Neuron. 2016; 92: 943-948

      Linked Article